Curative gene therapies for rare diseases - PMC
Diseases caused by alterations in the DNA can be overcome by providing the cells or tissues with a functional copy of the mutated gene. The most common form of gene therapy implies adding an extra genetic unit into the cell. However, new genome engineering ...
J Community Genet . 2020 Aug 15;12(2):267–276. doi: 10.1007/s12687-020-00480-6 Curative gene therapies for rare diseases Rocio Maldonado Rocio Maldonado 1 Stem Cells and Metabolism Research Program, University of Helsinki, Helsinki, Finland Find articles by Rocio Maldonado 1 , Sami Jalil Sami Jalil 1 Stem Cells and Metabolism Research Program, University of Helsinki, Helsinki, Finland Find articles by Sami Jalil 1 , Kirmo Wartiovaara Kirmo Wartiovaara 1 Stem Cells and Metabolism Research Program, University of Helsinki, Helsinki, Finland 2 Clinical Genetics, Helsinki University Hospital, Helsi
Explore this link on the map →related reading
- Significantly Enhancing Adult Intelligence With Gene Editing May Be Possible — LessWronglesswrong.com
- Medical breakthroughs in 2025 - by Saloni Dattaniscientificdiscovery.dev
- Frontiers | Current and Future Prospects for Gene Therapy for Rare Genetic Diseases Affecting the Brain and Spinal Cordfrontiersin.org
- Medicine's Endgamenotboring.co
- FDA Approves First CRISPR Gene Editing Treatment for Sickle Cell Disease | Scientific Americanscientificamerican.com
- Viral vector platforms within the gene therapy landscape | Signal Transduction and Targeted Therapynature.com
- Delivering gene therapy’s promise - Dyno Therapeuticsdynotx.substack.com
- Nature's drug database - The Works in Progress Newsletterworksinprogress.news
- This baby boy was treated with the first personalized gene-editing drug | MIT Technology Reviewtechnologyreview.com
- Large NIH Grant Supports CRISPR-based Gene Therapy Development for Brain Diseases | Yale School of Medicinemedicine.yale.edu
- The CRISPR web pagewwwuser.cnb.csic.es
- Clinical use of lentiviral vectors | Leukemianature.com